SCHEMBL14780793

SCHEMBL14780793

CNC(CC(=O)N=O)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12157037 0.77 ALDH1A1 (0.43) —
SCHEMBL13474987 0.77 ALDH1A1 (0.43) —
SCHEMBL16364137 0.75 MME (0.36) —
SCHEMBL8228271 0.75 SLC22A6 (0.38) —
SCHEMBL16656708 0.75 SLC22A6 (0.38) —
SCHEMBL8368760 0.75 SLC22A6 (0.38) —
SCHEMBL13164033 0.73 KDM4E (0.31) —
SCHEMBL20960290 0.73 — —
SCHEMBL17617892 0.73 MCL1 (0.34) —
SCHEMBL12661237 0.73 ECE1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805250-A1 IMPROVED 18F - TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER Deutsches Krebsforschungszentrum (DE) 2021-04-14 — — EP disclosed
US-8399827-B1 Mass spectrometry systems CEDARS-SINAI MEDICAL CENTER (US) 2013-03-19 — — US disclosed
Send feedback